Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran K Parwani

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|June 24, 2022
Medulloblastoma and the DNA Damage ResponseLeon F McSwain, Kiran K Parwani, Shubin W Shahab, et al.
Cancer Research Communications|March 27, 2023
Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast CancerRobert B Jones, Jonathan Farhi, Miranda Adams, et al.
Frontiers in Immunology|March 15, 2024
Directing the migration of serum-free, <i>ex vivo</i>-expanded Vγ9Vδ2 T cellsKiran K Parwani, Gianna M Branella, Rebecca E Burnham, et al.
Frontiers in Immunology|November 29, 2023
Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemiaGianna M Branella, Jasmine Y Lee, Jennifer Okalova, et al.
Cell Reports. Medicine|June 21, 2023
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastomaJasmine Y Lee, Hunter C Jonus, Arhanti Sadanand, et al.
Journal of the American Chemical Society|February 25, 2025
Dynamic <i>In Vivo</i> Mapping of the Methylproteome Using a Chemoenzymatic ApproachJonathan Farhi, Benjamin Emenike, Richard S Lee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|June 24, 2022
Medulloblastoma and the DNA Damage ResponseLeon F McSwain, Kiran K Parwani, Shubin W Shahab, et al.
Cancer Research Communications|March 27, 2023
Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast CancerRobert B Jones, Jonathan Farhi, Miranda Adams, et al.
Frontiers in Immunology|March 15, 2024
Directing the migration of serum-free, <i>ex vivo</i>-expanded Vγ9Vδ2 T cellsKiran K Parwani, Gianna M Branella, Rebecca E Burnham, et al.
Frontiers in Immunology|November 29, 2023
Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemiaGianna M Branella, Jasmine Y Lee, Jennifer Okalova, et al.
Cell Reports. Medicine|June 21, 2023
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastomaJasmine Y Lee, Hunter C Jonus, Arhanti Sadanand, et al.
Journal of the American Chemical Society|February 25, 2025
Dynamic <i>In Vivo</i> Mapping of the Methylproteome Using a Chemoenzymatic ApproachJonathan Farhi, Benjamin Emenike, Richard S Lee, et al.
Pageof 1